|
|
International Conference and Exhibition on
Bioequivalence & Bioavailability
|
Marriott Hotel & Convention Center,
Hyderabad, India,
01-03 March, 2010
|
|
Scientific Programme
|
| Track Information |
|
| Track 1: Practical Solutions to Pharmaceutical Bioequivalence/Bioavailability Implementation |
|
| Time |
Track |
March 1, 2010
(Monday)
13:00-18:00 |
Track 1-1: Bioequivalence Strategies in Development-an Industry Perspective |
| Session Chair: |
Dr. Sam H. Haidar, Lead Pharmacologist,
Office of Generic Drugs,
Food and Drug Administration,
Rockville, Maryland. |
| Session
Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: Recent Advances in the Evaluation of Bioequivalence
Dr. Sam H. Haidar, Lead Pharmacologist,
Office of Generic Drugs,
Food and Drug Administration,
Rockville, Maryland. |
| 13:30-13:55 |
Title: TBD
Dr. Faming Zhang,
Crown Bioscience Inc.,
No. 21 Huoju Street, Changping District, Beijing, P.R.China. |
| 13:55-14:20 |
Title: TBD
Dr. Subhash C. Basu,
UNIVERSITY OF NOTRE DAME
NOTRE DAME, INDIANA 46556,
Department of Chemistry
and Biochemistry. |
| 14:20-14:45 |
Title: TBD
Dr. Limin Chen,
University of Toronto,
Toronto, ON M5G 1L6, Canada. |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 1, 2010
(Monday)
13:00-18:00 |
Track 1-2: Comparative Bioavailability Studies for New Drugs (NDA) |
| Session Chair: |
Dr. Yellela Sri Rama Krishnaiah, Associate Professor of Pharmaceutics,
Department of Pharmaceutical Sciences,
College of Pharmacy,
Nova Southeastern University,
3200 South University Drive,
Fort Lauderdale. |
| Session
Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: TBD
Dr. Yellela Sri Rama Krishnaiah,
Associate Professor of Pharmaceutics,
Department of Pharmaceutical Sciences,
College of Pharmacy,
Nova Southeastern University, 3200 South University Drive, Fort Lauderdale. |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Title: TBD
Dr. Rachel W. Li,
Trauma and Orthopaedic Research Laboratory,
The Australian National University Medical School,
University of Canberra,
Division of Immunology and Genetics, JCSMR,
Australia. |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 1, 2010
(Monday)
13:00-18:00 |
Track 1-3: Comparative Bioavailability Generic Drug Products (ANDA): Bioequivalence Studies |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Dr. Ashwini Nangia,
School of Chemistry, University of Hyderabad, Hyderabad 500 046, INDIA. |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: TBD
Dr. Monika Pawłowska, Institute of Biotechnology and Antibiotics, Warsaw, Poland. |
| 13:30-13:55 |
Title: TBD
Dr. Fakhrul Ahsan, Department of Pharmaceutical Sciences,
Texas Tech School of Pharmacy,
Amarillo, TX-79106. |
| 13:55-14:20 |
Title: TBD
Dr. Ashwini Nangia,
School of Chemistry, University of Hyderabad, Hyderabad 500 046, INDIA. |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 1, 2010
(Monday)
13:00-18:00 |
Track 1-4: Implementing BA/BE Guidelines and CRO Qualification Criteria |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Dr. Idkaidek, College of Pharmacy & Medical Sceinces,
University of Petra,
Amman, Jordan. |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: Effect of Truncated AUC Method on Drug Bioequivalence in Humans: an EMEA Draft Guideline Evaluation
Dr. Idkaidek, College of Pharmacy & Medical Sceinces,
University of Petra,
Amman, Jordan. |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
|
| Welcome Banquet : March 01, 2010 Call for sponsor! |
|
|
| Track 2: Pharmacokinetic/Pharmacodynamic Models, Biowaivers and Biosimilars |
|
| Time |
Track |
March 2, 2010
(Tuesday)
8:30-12:00 |
Track 2-1: Human/Animal Models in Oral Drug Absorption |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: TBD
Dr. Xiaoyan Jiang, MD,
Medical Genetics,
University of British Columbia,
Senior Scientist, Terry Fox Laboratory,
BC Cancer Research Centre,
675 West 10th Avenue,
Vancouver, BC V5Z 1L3. |
| 9:00-9:25 |
Title: Inter individual variability and science of drug development
Dr. Harih Padh,
Director,
B. V. Patel Perd Centre,
Thaltej-gandhinagar highway,
Thaltej,
Ahmedabad-380054. |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
13:00-18:00 |
Track 2-2: Biosimilars and Biowaivers |
| Session Chair: |
Dr. Barbara M Davit, US Food and Drug Administration,
Center for Drug
Evaluation and Research, Office of Generic Drugs,
7520 Standish Place, Rockville, Maryland 20855, USA. |
| Session Co-Chair: |
call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: TBD
Dr. Barbara M Davit, US Food and Drug Administration,
Center for Drug
Evaluation and Research, Office of Generic Drugs,
7520 Standish Place, Rockville, Maryland 20855, USA. |
| 13:30-13:55 |
Title: Biosimilars and follow-on biologics
Dr. Fuhr Joseph P, Widener University, One University Place, Chester, PA 19013, USA. |
| 13:55-14:20 |
Title: Biosimilar Epoetins in Europe - A success story?
Dr. David Goldsmith, Renal Unit, New Guy House,Guy's Hospital, London, UK. |
| 14:20-14:45 |
Title: The importance of the human placenta ex vivo model in the drug development for human pregnancy
Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics,
Research Division,
Frauenklinikstr. 10,
8091 Zurich, Switzerland. |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Title: European regulations in the context of biosimilars
Dr. Jean-Louis Prugnaud, Chef de Service,
Hôpital Saint-Antoine,
184 rue du Fbg Saint-Antoine,
75012 PARIS. |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
8:30-12:00 |
Track 2-3: Biosimulation in BE Studies-Prediction Tools |
| Session Chair: |
Dr. Srinubabu Gedela,
Stanford University School of Medicine, USA. |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Speech Opportunity Available |
| 9:00-9:25 |
Title: TBD
Dr. Janaina Fernandes,
Universidade Federal do Rio de Janeiro,
Institute of Biophysics Carlos Chagas,
Filho, Laboratory of Cellular Immunology,
RJ - Brasil. |
| 9:25-9:50 |
Title: TBD
Dr. Alexey Goltsov,
Centre for Systems Biology of Edinburgh,
School of Biological Sciences,
University of Edinburgh,
The Kings Buildings, Mayfield Road,
Edinburgh, EH9 3JU, UK. |
| 9:50-10:15 |
Title: TBD
Dr. Hsin-Yun HSU,
Laboratory of Medical Genomics,
Department of Human Genome Research,
Kazusa DNA Research Institute,
Kisarazu, Chiba, JAPAN. |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
13:00-18:00 |
Track 2-4: Statistical Issues in BA/BE |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Speech Opportunity Available |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
8:30-12:00 |
Track 2-5: In Vivo/In Vitro Methods to Determine Bioavailability |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: Magnetic Resonance Imaging studies as a source of additional information on controlled release formulations behaviour during dissolusion. Towards the enhancement of reliability and rationalization of formulation selection for BE studies
Dr. Piotr Kulinowski, Department of Magnetic Resonance Imaging,
Institute of Nuclear Physics, Polish Academy of Sciences,
Poland. |
| 9:00-9:25 |
Speech Opportunity Available |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
13:00-18:00 |
Track 2-6: Role of Drug Delivery Systems in Bioequivalence and Bioavailability |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: Role of drug delivery systems in enhancing the bioavailability of poorly soluble and/or poorly permeable drugs
Dr. Praveen Hiremath, Product Development,
Pharmaceutics International, Inc.,
10189 Gilroy Road,
Hunt Valley, MD, USA. |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
|
| Track 3: Bioanalytical Methodology Development and Validation Using HPLC and LCMS |
|
| Time |
Track |
March 2, 2010
(Tuesday)
8:30-12:00 |
Track 3-1: Advances in Mass Spectrometry Methodology Development |
| Session Chair: |
Dr. Tanay Waingankar, Life Science Industry Marketing Manager,
Life Science & Chemical Analysis Division,
G01, Andheri (E), Mumbai, India. |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: TBD
Dr. Tanay Waingankar, Life Science Industry Marketing Manager,
Life Science & Chemical Analysis Division,
G01, Prime Corporate Park,
230/231, Sahar Road, Andheri (E), Mumbai-99. |
| 9:00-9:25 |
Speech Opportunity Available |
| 9:25-9:50 |
Title: TBD
Dr. Sotiris Athanaselis, Associate Professor of Toxicology,
Department of Forensic Medicine and Toxicology,
Medical School,
University of Athens,
Greece. |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
13:00-18:00 |
Track 3-2: Antiviral, Anti Retroviral, Antibacterial and Anti Fungal Drugs |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: TBD
Dr. Silvia Lima Costa,
Laboratorio de Neuroquimica e Biologia Celular,
Universiade Federal da Bahia,
Instituto de Ciências da Saude,
Brazil. |
| 13:30-13:55 |
Title: TBD
Dr. Sotiris Athanaselis, Associate Professor of Toxicology,
Department of Forensic Medicine and Toxicology,
Medical School,
University of Athens,
Greece. |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
8:30-12:00 |
Track 3-3: Drugs Acting on Central Nervous Systems |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: Bioequivalence of generic antiepilepsy drugs
Dr. Gregory Krauss, MD,
Professor of Neurology,
Johns Hopkins University,
Baltimore, MD, USA. |
| 9:00-9:25 |
Speech Opportunity Available |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
13:00-18:00 |
Track 3-4: Anticancer/Anti-Neovascular Drugs |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Dr. Sudhakar Akulapalli,
Creighton University Medical Center and University of Nebraska Medical Center.
Director & Coordinator: Cell Signaling and Tumor Angiogenesis Laboratory,
Boys Town National Research Hospital,
Omaha, USA. |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: TBD
Dr. Ney Carter do Carmo Borges, MD, PhD, FACC, FESC, FACP, FAHA, FASCPT,
Post Graduate Professor FCM UNICAMP,
Principal Investigator Synchrophar Clinical Trials. |
| 13:30-13:55 |
Title: Signaling Mechanisms of Endogenous Anti-cancer Molecules Derived From Extra Cellular Matrix Type IV Collagen
Dr. Sudhakar Akulapalli,
Creighton University Medical Center and University of Nebraska Medical Center.
Director & Coordinator: Cell Signaling and Tumor Angiogenesis Laboratory,
Boys Town National Research Hospital,
Omaha, USA. |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
|
| Track 4: IP, Regulatory Affairs and Outsourcing Alliance |
|
| Time |
Track |
March 2, 2010
(Tuesday)
8:30-12:00 |
Track 4-1: Clinical Data Harmonization Across Countries |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: TBD
Dr. Xia Yang,
Principle Systems Biologist,
Sage Bionetworks,
1100 Fairview Ave N, Room M2-C833,
Seattle, WA 98109, USA. |
| 9:00-9:25 |
Speech Opportunity Available |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
13:00-18:00 |
Track 4-2: ICH/FDA Guidelines and Regulatory Updates |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Speech Opportunity Available |
| 13:30-13:55 |
Title: PK-PD integration/modeling of NSAID in veterinary pharmacology
Prof. Mario Giorgi, Pharmacology & Toxicology Section,
University of Pisa,
V.le delle Piagge 2,
56124 Pisa, Italy. |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
8:30-12:00 |
Track 4-3: Partnerships with Animal Research Centres, Universities and Non-Profits |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Speech Opportunity Available |
| 9:00-9:25 |
Speech Opportunity Available |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 2, 2010
(Tuesday)
13:00-18:00 |
Track 4-4: Perspectives of Regulatory Agencies, Worldwide, on Bioequivalence Testing. |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Speech Opportunity Available |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
|
|
|
| Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 5-1: Biomarkers in Toxicology |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Dr. Rita Mattos, Senior Researcher,
National School of Public Health,
Fundação Oswaldo Cruz,
Ministry of Health. |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: TBD
Dr. Kar Chowdhuri, Scientist F and Deputy Director,
Embryotoxicology Lab,
Indian Institute of Toxicology Research,
P.O. Box No. 80,
Mahatma Gandhi Marg,
Lucknow 226 001,
Uttar Pradesh,
India. |
| 8:35-9:00 |
Title: Advances and strategies in using biomarkers in children lead exposure
Dr. Rita Mattos, Senior Researcher,
National School of Public Health,
Fundação Oswaldo Cruz,
Ministry of Health. |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 5-2: Toxicogenomics & Metabolomics |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Speech Opportunity Available |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 5-3: Environmental Toxicology |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Speech Opportunity Available |
| 9:00-9:25 |
Speech Opportunity Available |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 5-4: Molecular Epidemiology |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Speech Opportunity Available |
| 13:30-13:55 |
Title: TBD
Dr. Yoshihiro Ishikawa, Dean, Graduate School of Medicine,
Professor and President,
Cardiovascular Research Institute,
Yokohama City University,
Graduate School of Medicine,
Japan. |
| 13:55-14:20 |
Title: TBD
Prof. Michael V. Miles, Clinical Pediatrics and Neurology,
Div. of Pathology & Laboratory Medicine,
Children's Hospital Medical Center,
3333 Burnet Ave.,
Cincinnati, OH 45229, USA. |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
|
| Track 6: PK/PD and Drug Discovery |
|
| Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 6-1: Anticacer, Antiviral Drug Development |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Dr. Guo Rui Chen, Institute of Clinical Pharmacology,Qilu Hospital of Shandong University, Jinan, Shandong, China. |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: TBD
Dr. Mitchell Ho,
Head, Antibody Therapy Unit,
Laboratory of Molecular Biology,
National Cancer Institute, NIH,
Bethesda, MD, USA. |
| 9:00-9:25 |
Title: Pharmacokinetics, Metabolism and Tissue Distribution of norcantharidin in human body, studied by HPLC-MS/MS and Isotope-labeled methods
Dr. Guo Rui Chen, Institute of Clinical Pharmacology,Qilu Hospital of Shandong University, Jinan, Shandong, China. |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Title: Quantitative Structure-Activity Relationship Studies on Anti-Hepatitis Viral Agents
Dr. S.P.Gupta, Departemt of Pharmaceutical Technology
Meerut Institute of Engineering and Technology, Meerut, India. |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Title: Targeted therapy for Treatment of Lung Cancer
Dr. Mandip Singh Sachdeva, Professor and section Leader, Pharmaceutics,
Florida A & M University,
College of Pharmacy
Editor in Chief, CRC Critical Reviews in Therapeutic Drug Carrier Systems,
Tallahassee, Florida, USA. |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 6-2: Molecular Drug Targets and Fragment based Drug Design |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: Assessment of exposure to carcinogens: correlation of surrogate biomarkers with adducts in target tissues
Dr. Franky Richter, Walther Straub Institute, Department of Toxicology, Ludwig-Maximilians University, Germany. |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 6-3: Improving ADME/DMPK Profile |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: TBD
Dr. Jian Li, Facility for Anti-infective Drug Development and Innovation,
Drug Delivery, Disposition and Dynamics,
Monash Institute of Pharmaceutical Sciences,
Monash University, Australia. |
| 9:00-9:25 |
Title: TBD
Dr. Hong Wan,
Lead Generation DMPK and Physical Chemistry,
AstraZeneca R&D Mölndal, Sweden. |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Title: TBD
Dr. William Jia,
Department of Surgery,
Faculty of Medicine,
University of British Columbia,
Brain Research Centre, Canada. |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 6-4: PK/PD and Bioanalysis Outsourcing Alliance |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Speech Opportunity Available |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
|
|
|
|
| Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 7-1: Influence of Disease on Bioavailability |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Speech Opportunity Available |
| 9:00-9:25 |
Title: TBD
Dr. Wei Zhang P,
Department of pharmacology,
Yale school of medicine, New Haven
Connecticut, USA. |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 7-2: Factors Influencing Bioavailability and Bioequivalence |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Title: Immunomodulation by biologic Intravenous Immunoglobulins IVIG: Immune Thrombocytopenia ITP as a Model for the last 30 Years
Dr. Paul Imbach, University Children's Hospital Basel UKBB, Basel, Switzerland. |
| 13:30-13:55 |
Title: Current Strategies for the Bioequivalence Assessment of Topical Dermatological Dosage Forms
Dr. Isadore Kanfer, Emeritus Professor,
Faculty of Pharmacy,
Rhodes University,
Grahamstown,
South Africa. |
| 13:55-14:20 |
Title: TBD
Dr. Peinan Sun,
The Department of Clinical Pharmacology,
Huashan hospital of Fudan University,
Shanghai, P. R. of China. |
| 14:20-14:45 |
Title: TBD
Dr. Motte Laurence,
Université Paris,
Nanomaterials group,
CSPBAT Laboratory,
France. |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Title: TBD
Dr. Ai-Guo Wu,
Division of Functional Materials and Nanodevices,
Ningbo Institute of Material Technology & Engineering (NIMTE),
Chinese Academy of Sciences (CAS),
Zhejiang, China. |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track 7-3: The Role of Intestinal Metabolism on Bioavailability |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 8:30-8:35 |
Session Introduction |
| 8:35-9:00 |
Title: Challenges in Establishing Bioequivalence of Complex Modified Release Dosage Forms
Dr. Salomon Stavchansky, Division of Pharmaceutics, College of Pharmacy,
University of Texas at Austin, Austin, Texas, USA. |
| 9:00-9:25 |
Title: TBD
Dr. Jonathan P. Wong, Defence Scientist,
Defence Research and Development Canada Suffield,
Recherche et dévelopment pour la défense Canada Suffield CP 4000, Succ. Main, Medicine Hat, Alberta Canada. |
| 9:25-9:50 |
Speech Opportunity Available |
| 9:50-10:15 |
Speech Opportunity Available |
| 10:15-10:25 |
Coffee Break |
| 10:25-10:50 |
Speech Opportunity Available |
| 10:50-11:15 |
Speech Opportunity Available |
| 11:15-11:40 |
Speech Opportunity Available |
| 11:40-12:00 |
Panel Discussion |
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track 7-4: In Vitro Methods to Determine Bioavailability: In Vitro-In Vivo Correlations |
| Session Chair: |
Call for Host |
| Session Co-Chair: |
Call for Co-Host |
| 13:00-13:05 |
Session Introduction |
| 13:05-13:30 |
Speech Opportunity Available |
| 13:30-13:55 |
Speech Opportunity Available |
| 13:55-14:20 |
Speech Opportunity Available |
| 14:20-14:45 |
Speech Opportunity Available |
| 14:45-16:20 |
Coffee Break & Poster Session |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
| 17:10-17:35 |
Speech Opportunity Available |
| 17:35-18:00 |
Panel Discussion |
|
|
| |
|
